Description of Medical ServiceImplantation of radio-opaque fiducial markers into the prostate gland or prostate surgical bed to assist in the delivery of external-beam radiotherapy. Fiducial markers serve as fiducial reference points during radiotherapy in patients with prostate cancer precisely identify the location of the cancer and deliver accurately guided radiation therapy.
Description of Medical ConditionProstate cancer is the most common cancer in men. Just over 16,000 cases of prostate cancer (nearly 30% of male cancers) are diagnosed each year in Australia and it is responsible for approximately 3,000 deaths annually. Prostate cancer tends to develop in men over the age of fifty. Patients with localised prostate cancer may be treated with radical prostatectomy or radical radiotherapy.
Reason for Application-
Medical Service Type-
Previous Application NumberNot Applicable
PICO ConfirmationRelease date: 25 July 2011 to 18 August 2011
Consultation Decision Analytic Protocol (DAP) (PDF 378 KB)
Consultation Decision Analytic Protocol (DAP) (Word 283 KB)
14 – 15 September 2011
Final Decision Analytic Protocol (DAP) (PDF 368 KB)
Final Decision Analytic Protocol (DAP) (Word 351 KB)
Assessment ReportContracted Assessment Report (PDF 1079 KB)
Contracted Assessment Report (Word 1301 KB)
Public Summary DocumentPublic Summary Document - August 2013 (PDF 172 KB)
Public Summary Document - August 2013 (Word 90 KB)